Insider Trading Alert - COBZ, ABAX And EVTC Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 10, 2014, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.29 to $203,469,000.00.

Highlighted Stocks Traded by Insiders:

CoBiz Financial (COBZ) - FREE Research Report

Dumlao Troy, who is SVP & Chief Accounting Officer at CoBiz Financial, sold 521 shares at $12.32 on Dec. 10, 2014. Following this transaction, the SVP & Chief Accounting Officer owned 16,222 shares meaning that the stake was reduced by 3.11% with the 521-share transaction.

The shares most recently traded at $12.04, down $0.28, or 2.33% since the insider transaction. Historical insider transactions for CoBiz Financial go as follows:

  • 4-Week # shares bought: 492
  • 4-Week # shares sold: 13,105
  • 12-Week # shares bought: 492
  • 12-Week # shares sold: 18,105
  • 24-Week # shares bought: 492
  • 24-Week # shares sold: 61,206

The average volume for CoBiz Financial has been 73,200 shares per day over the past 30 days. CoBiz Financial has a market cap of $494.4 million and is part of the financial sector and banking industry. Shares are up 3.93% year-to-date as of the close of trading on Tuesday.

CoBiz Financial Inc., a diversified financial services company, provides various banking and financial products and services in the United States. The stock currently has a dividend yield of 1.32%. The company has a P/E ratio of 17.4. Currently, there are 3 analysts who rate CoBiz Financial a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on COBZ - FREE

TheStreet Quant Ratings rates CoBiz Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, notable return on equity, expanding profit margins and increase in net income. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full CoBiz Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Abaxis (ABAX) - FREE Research Report

Aron Kenneth, who is Chief Technology Officer at Abaxis, sold 2,000 shares at $56.68 on Dec. 10, 2014. Following this transaction, the Chief Technology Officer owned 76,518 shares meaning that the stake was reduced by 2.55% with the 2,000-share transaction.

The shares most recently traded at $55.60, down $1.08, or 1.95% since the insider transaction. Historical insider transactions for Abaxis go as follows:

  • 4-Week # shares sold: 12,286
  • 12-Week # shares sold: 49,559
  • 24-Week # shares sold: 78,590

The average volume for Abaxis has been 217,200 shares per day over the past 30 days. Abaxis has a market cap of $1.3 billion and is part of the health care sector and health services industry. Shares are up 43.36% year-to-date as of the close of trading on Tuesday.

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The stock currently has a dividend yield of 0.71%. The company has a P/E ratio of 73.6. Currently, there is 1 analyst who rates Abaxis a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ABAX - FREE

TheStreet Quant Ratings rates Abaxis as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Abaxis Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Evertec (EVTC) - FREE Research Report

Harrington Peter, who is President & CEO at Evertec, sold 10,550 shares at $22.46 on Dec. 10, 2014. Following this transaction, the President & CEO owned 70,372 shares meaning that the stake was reduced by 13.04% with the 10,550-share transaction.

The shares most recently traded at $21.75, down $0.71, or 3.26% since the insider transaction. Historical insider transactions for Evertec go as follows:

  • 4-Week # shares sold: 247,722
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 272,722
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 309,722

The average volume for Evertec has been 347,100 shares per day over the past 30 days. Evertec has a market cap of $1.7 billion and is part of the technology sector and computer software & services industry. Shares are down 8.96% year-to-date as of the close of trading on Tuesday.

EVERTEC, Inc. provides various transaction processing services in Latin America and the Caribbean. The company operates in three segments: Merchant Acquiring, Payment Processing, and Business Solutions. The stock currently has a dividend yield of 1.81%. The company has a P/E ratio of 8.0. Currently, there are 4 analysts who rate Evertec a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EVTC - FREE

TheStreet Quant Ratings rates Evertec as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including relatively poor performance when compared with the S&P 500 during the past year and generally higher debt management risk. Get the full Evertec Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists